Can a Stress-Busting program help VHL patients cope better?
NCT ID NCT05737602
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a specially adapted stress management program called 3RP-VHL for adults with von Hippel-Lindau disease (VHL), a genetic condition that causes tumors. The program teaches relaxation and resilience skills through 8 video sessions. Researchers want to see if it is feasible and acceptable to patients. Only 40 people will take part, and the focus is on coping, not treating the disease itself.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Relaxation Response Resiliency Program for VHL (behavioral intervention)
- What this could lead to
- If successful, this program could provide a practical way for people with VHL to better manage stress and improve their quality of life.
- What could go wrong
- This is a very small pilot study with only 40 participants, so results may not apply to everyone. The program is behavioral, not a medical treatment, and may not reduce disease progression or physical symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENETIC DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists track hidden brain tumors in children with rare genetic condition
- Gene therapy readiness check: new study maps virus immunity in muscle disease patients
- New PET scan agent aims to sharply detect multiple cancers
- Testosterone levels linked to brain health in new genetic analysis
- Belzutifan extension trial aims to extend lives in VHL and advanced cancer
- Frozen tumors, clearer vision? scientists dig into 20 years of eye records